ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Rheumatology

Top Rheumatology Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANGEL VIDAL M.D.

Rheumatology

14,861

$2.06M

1272
1106 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$139
Average prescription price

Avg: $147

JOSE ROVIRA MD

Rheumatology

10,323

$1.08M

1423
1324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $147

JAVAID SHEIKH MD FACP MRCP UK

Rheumatology

10,288

$1.67M

912
580 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $147

YONG TSAI M.D.

Rheumatology

9,952

$982K

906
650 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$99
Average prescription price

Avg: $147

GEORGE WINEBURGH MD

Rheumatology

9,317

$341K

458
411 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$37
Average prescription price

Avg: $147

HARRY WILKS M.D.

Rheumatology

8,523

$475K

355
317 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $147

BENIDECTO FERNANDEZ MD

Rheumatology

7,290

$2.03M

705
599 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$279
Average prescription price

Avg: $147

AZAREL ABINADER M.D.

Rheumatology

7,102

$1.4M

769
695 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$197
Average prescription price

Avg: $147

DAVID SIKES MD

Rheumatology

7,001

$1.67M

701
508 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$238
Average prescription price

Avg: $147

THOMAS LLOYD MD

Rheumatology

6,838

$365K

436
321 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $147

ABDUL AZIZ M.D.

Rheumatology

6,712

$757K

828
487 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $147

RICHARD CHANG M.D.

Rheumatology

6,674

$655K

477
325 are 65+

25%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$98
Average prescription price

Avg: $147

STEPHEN BOOKBINDER M.D.

Rheumatology

6,589

$742K

584
425 are 65+

14%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $147

DAVID BALDINGER M.D.

Rheumatology

6,442

$832K

619
451 are 65+

15%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $147

KARAMALI BANDEALY M.D.,

Rheumatology

6,426

$855K

641
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $147

MAURICE MCCARTHY MD

Rheumatology

6,147

$888K

404
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

32%
prescriptions for brand name drugs

Avg: 24%

$144
Average prescription price

Avg: $147

RANJU WADHWA MD

Rheumatology

6,025

$949K

675
461 are 65+

10%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$158
Average prescription price

Avg: $147

MOHAMMED MUGHNI MD

Rheumatology

5,988

$450K

767
594 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $147

MIGUEL GONZALEZ MD

Rheumatology

5,832

$865K

953
814 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $147

NANCY MORRIS MD

Rheumatology

5,735

$434K

469
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $147

MICHAEL ROZBORIL MD

Rheumatology

5,694

$518K

328
255 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$91
Average prescription price

Avg: $147

GEORGE CLEMENT MD.

Rheumatology

5,639

$789K

712
602 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$140
Average prescription price

Avg: $147

AMARILIS TORRES MD

Rheumatology

5,564

$1.02M

396
235 are 65+

27%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$183
Average prescription price

Avg: $147

HOWARD OFFENBERG MD

Rheumatology

5,517

$473K

575
427 are 65+

9%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $147

MICHELLE SPUZA MILORD MD

Rheumatology

5,465

$298K

595
392 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $147

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank